These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6461813)

  • 1. [Clinical experiences with cefoperazone. A new cephalosporine derivative for pulmonary infections].
    Liener A
    Med Welt; 1982 Feb; 33(5):188-90. PubMed ID: 6461813
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study on the new derivative of cephalosporine called cefradine].
    von Perjés OC
    Med Welt; 1974 Sep; 25(39):1564-8. PubMed ID: 4427555
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study of 25 patients treated with cefoperazone, a 3d generation cephalosporin].
    Clément M; Regamey C
    Rev Med Suisse Romande; 1982 Sep; 102(9):833-8. PubMed ID: 6216572
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of a new drug combination in the therapy of acute and chronic bronchopneumopathies].
    Olivieri D; Pezza A; Polistina D; D'Agostino F
    Arch Monaldi; 1979; 34(1-2):29-41. PubMed ID: 554572
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of aztreonam in the treatment of acute and flare-ups of chronic infectious bronchopneumopathies].
    Aquino G; Barbera S; Romano F; Zottola V
    Clin Ter; 1988 Jan; 124(2):109-16. PubMed ID: 2973921
    [No Abstract]   [Full Text] [Related]  

  • 6. [3-stage aerosol therapy of bronchopulmonary diseases in children].
    Zemliakova ZM; Matveeva LA; Osin AIa
    Vopr Kurortol Fizioter Lech Fiz Kult; 1978; (1):20-4. PubMed ID: 345617
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on a new bronchospasmolytic agent from the group of antihistaminics].
    Herberg D; Utz G
    Dtsch Med Wochenschr; 1969 Jan; 94(4):153-7. PubMed ID: 4387343
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with a new secretolytic drug.
    Villa R; Orlandini GC
    Minerva Med; 1969 Sep; 60(76):3607-10. PubMed ID: 5823759
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of the use of delayed-action sulfamides in chronic broncho-pulmonary infections (46 cases)].
    Kleisbauer JP; Kleisbauer A; Lafont C; Moreno JP
    Mars Med; 1970; 107(10):835-7. PubMed ID: 5476982
    [No Abstract]   [Full Text] [Related]  

  • 10. [Apropos of a new anti-inflammatory medication in broncho-pulmonary pathology].
    Alex R; Robert M
    J Med Lyon; 1965 Jun; 46(78):1111-6. PubMed ID: 5888707
    [No Abstract]   [Full Text] [Related]  

  • 11. A multicenter clinical study of cefoperazone.
    Alix M; Arreza V; Brillantes S; Estrellado R; Gempesaw C; Monteron R; Pascasio F; Pena A; Claudio-Saniel M
    Clin Ther; 1984; 6(3):344-53. PubMed ID: 6722861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cefatrizine in the ambulatory treatment of recurring chronic bronchial infections].
    Fantoni U; Miglioli PA
    Riv Eur Sci Med Farmacol; 1987 Sep; 9(3):327-30. PubMed ID: 3508607
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of a broncho-secretolytic in lung specialties with the help of a simple measuring method].
    Wilde W
    Arztl Forsch; 1966 Mar; 20(3):149-56. PubMed ID: 6014420
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibiotic association of demethylchlortetracycline and erythromycin propionate laurysulfate in treatment of lung and bronchial diseases].
    Carreri V
    Policlinico Prat; 1965 Aug; 72(35):1165-76. PubMed ID: 4954826
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cefalexine in pulmonary complications of influenza].
    Jeune M; Jandot V; de Mongolfier R; Plauchu M
    Lyon Med; 1970 Apr; 223(14):773-7. PubMed ID: 5429539
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of bronvho-pulmonary obstructive disease states.
    Lipman WH
    Med Times; 1967 Dec; 95(12):1295-302. PubMed ID: 6081119
    [No Abstract]   [Full Text] [Related]  

  • 17. [Responsiveness of the bronchial tree, assessed by means of pharmacological tests, in patients with chronic non-specific broncho-pulmonary diseases].
    Kurgan J
    Gruzlica; 1970; 38(7):663-71. PubMed ID: 5453675
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinical trial with cefoperazone in pneumonia and pyelonephritis.
    Park SC; Lee JH; Lee DH; Kim SY; Kim YH; Park CH; Seok SE; Lee YK; Chung BC; Sohn ES
    Drugs; 1981; 22 Suppl 1():72-5. PubMed ID: 6456894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new contribution to the treatment of chronic bronchopneumopathies: letosteine].
    Macquet V; Ficheroulle X; Ta Van P; Peltier M
    Lille Med; 1979 Nov; 24(9):735-8. PubMed ID: 529981
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mezlocillin in the treatment of acute bronchopneumopathies caused by gram-negative organisms].
    Cioffi R; Cristiano P; Paradisi F
    Arch Monaldi; 1980; 35(5-6):291-300. PubMed ID: 6212038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.